The global need for effective antibiotics-Moving towards concerted action

被引:63
作者
Cars, Otto [1 ]
Hedin, Anna [1 ]
Heddini, Andreas [1 ]
机构
[1] Uppsala Univ, SE-75105 Uppsala, Sweden
关键词
Antibiotic resistance; Antibacterial; Globalization; Health systems; Microbiology; Surveillance; Rational use of drugs; Innovation; Drug regulation; Pharmacology; Clinical trials; Drug discovery; Bacterial infections; Emerging infectious diseases;
D O I
10.1016/j.drup.2011.02.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Antibiotic resistance has emerged as one of the greatest global health challenges to be addressed in the 21st Century. The risk of widespread antibiotic resistance threatens to mitigate the positive changes made in modernizing healthcare systems; therefore, fresh approaches are essential, as well as new and effective antibacterial drugs. In a globalized world, a spectrum of different interventions and health technologies must be employed to contain antibiotic resistance. Finding ways of accelerating the development of new drugs and diagnostic tools is one strategy, as is better surveillance of antibiotic resistance and ways of improving use of existing antibiotics. Moreover, a framework to regulate use is called for to avoid that potential new antibiotics are squandered. Finally, the ongoing pandemic spread of resistant bacteria illustrates that the problem can only be addressed through international cooperation and thus that any new strategy to manage antibiotic resistance must take into consideration issues of global access and affordability. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:68 / +
页数:2
相关论文
共 9 条
[1]  
[Anonymous], 2009, ECDC and EMEA joint technical report
[2]   The role of the pharmaceutical industry in meeting the public health threat of antibacterial resistance [J].
Bergstrom, Richard .
DRUG RESISTANCE UPDATES, 2011, 14 (02) :77-78
[3]   Antimicrobial resistance predicts death in Tanzanian children with bloodstream infections: a prospective cohort study [J].
Blomberg, Bjorn ;
Manji, Karim P. ;
Urassa, Willy K. ;
Tamim, Bushir S. ;
Mwakagile, Davis S. M. ;
Jureen, Roland ;
Msangi, Viola ;
Tellevik, Marit G. ;
Holberg-Petersen, Mona ;
Harthug, Stig ;
Maselle, Samwel Y. ;
Langeland, Nina .
BMC INFECTIOUS DISEASES, 2007, 7 (1)
[4]   Fighting bacterial infections-Future treatment options [J].
Fernebro, Jenny .
DRUG RESISTANCE UPDATES, 2011, 14 (02) :125-139
[5]   Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now [J].
Freire-Moran, Laura ;
Aronsson, Bo ;
Manz, Chris ;
Gyssens, Inge C. ;
So, Anthony D. ;
Monnet, Dominique L. ;
Cars, Otto .
DRUG RESISTANCE UPDATES, 2011, 14 (02) :118-124
[6]   A framework for global surveillance of antibiotic resistance [J].
Grundmann, Hajo ;
Klugman, Keith P. ;
Walsh, Timothy ;
Ramon-Pardo, Pilar ;
Sigauque, Betuel ;
Khan, Wasif ;
Laxminarayan, Ramanan ;
Heddini, Andreas ;
Stelling, John .
DRUG RESISTANCE UPDATES, 2011, 14 (02) :79-87
[7]   Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective [J].
Mouton, Johan W. ;
Ambrose, Paul G. ;
Canton, Rafael ;
Drusano, George L. ;
Harbarth, Stephan ;
MacGowan, Alasdair ;
Theuretzbacher, Ursula ;
Turnidge, John .
DRUG RESISTANCE UPDATES, 2011, 14 (02) :107-117
[8]   Diagnostics as essential tools for containing antibacterial resistance [J].
Okeke, Iruka N. ;
Peeling, Rosanna W. ;
Goossens, Herman ;
Auckenthaler, Raymond ;
Olmsted, Stuart S. ;
de Lavison, Jean-Francois ;
Zimmer, Barbara L. ;
Perkins, Mark D. ;
Nordqvist, Katarina .
DRUG RESISTANCE UPDATES, 2011, 14 (02) :95-106
[9]   Towards new business models for R&D for novel antibiotics [J].
So, A. D. ;
Gupta, N. ;
Brahmachari, S. K. ;
Chopra, I. ;
Munos, B. ;
Nathan, C. ;
Outterson, K. ;
Paccaud, J. P. ;
Payne, D. J. ;
Peeling, R. W. ;
Spigelman, M. ;
Weigelt, J. .
DRUG RESISTANCE UPDATES, 2011, 14 (02) :88-94